Sclerotherapy of telangiectasias using 0 Sclerotherapy of telangiectasias using 0.2% sodium tetradecyl sulfate before (left) and 8 weeks after treatment (right). Source: Lower Extremity Venous Disease, Venous and Lymphatic Diseases Citation: Dieter RS, Dieter RA, Jr., Dieter RA, III. Venous and Lymphatic Diseases; 2016 Available at: http://accesscardiology.mhmedical.com/DownloadImage.aspx?image=/data/books/1782/dieven_ch30_f007b.png&sec=121399581&BookID=1782&ChapterSecID=121399534&imagename= Accessed: November 05, 2017 Copyright © 2017 McGraw-Hill Education. All rights reserved